Article
Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureus
5 Aug 2024
Abstract excerpt
Infections caused by Staphylococcus aureus pose a significant global public problem. Therefore, new antibiotics and therapeutic strategies are needed to combat this pathogen. This investigation delves into the effects of iclaprim, a newly discovered inhibitor of folic acid synthesis, on S. aureus virulence. The phenotypic and genotypic effects of iclaprim were thoroughly examined in relation to virulence factors,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
